LENA LANGER: Open Payments
NPI 1124166640 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,069 in 89 payments from 18 companies in 2025. Trend: 2023 $1,757 · 2024 $2,026 · 2025 $2,069
Food & beverage: $1,974Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $406 |
| LEO Pharma Inc. | 11 | $372 |
| Galderma Laboratories, L.P. | 13 | $226 |
| Incyte Corporation | 4 | $209 |
| UCB, Inc. | 12 | $196 |
| Novartis Pharmaceuticals Corporation | 5 | $129 |
| Botanix SB Inc | 6 | $113 |
| ABBVIE INC. | 5 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Amgen Inc. | 3 | $57 |
Products named: TREMFYA, OPZELURA, Bimzelx, NEMLUVIO, ANZUPGO, ADBRY, SOFDRA, COSENTYX.
Industry payments across NY — which companies pay providers there.
